GSK files Form 6-K reporting 10,050 shares traded Sep 04, 2025

Rhea-AI Filing Summary

GSK plc filed a Form 6-K reporting a transaction notification dated September 04, 2025. The filing identifies the security by ISIN GB00BN7SWP63 and discloses an aggregated volume of 10,050 shares. The document provides the transaction date and quantity but does not state the transaction price, the identity of the reporting person or counterparty, or aggregated price information.

Positive

• Transaction date disclosed: September 04, 2025
• Security identified by ISIN GB00BN7SWP63
• Share volume disclosed: 10,050

Negative

• Transaction price not provided in the supplied text
• Reporting party identity missing from the provided content
• Aggregated price information absent, preventing value calculation

Insights

Corporate Actions Analyst

Disclosure shows a 10,050-share transaction on September 04, 2025 but key details are missing.

The filing identifies the security by ISIN GB00BN7SWP63 and reports an aggregated volume of 10,050 shares. It confirms the transaction date but does not include the transaction price or the reporting party's identity in the provided text.

Because price and reporting-party details are not present in the supplied content, investors cannot assess the size of the trade relative to the issuer's outstanding shares or determine whether the trade was insider-related or routine market activity.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2025

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

GSK plc (the 'Company')

Transaction notification

​

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Victoria Whyte
b)	Position/status	SVP & Company Secretary
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB00BN7SWP63
b)	Nature of the transaction	Award of Ordinary Shares under the Company's 2025 Share Value Plan
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£14.4250	10,050
		d)	Aggregated information	N/A (single transaction)
Aggregated volume Price
e)	Date of the transaction	2025-09-02
f)	Place of the transaction	N/A

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

GSK plc

(Registrant)

Date: September 04, 2025

By:/s/ VICTORIA WHYTE

--------------------------

Victoria Whyte

Authorised Signatory for and on

behalf of GSK plc

FAQ

What transaction did GSK (GSK) disclose on September 04, 2025?

The filing discloses a transaction involving 10,050 shares of the security with ISIN GB00BN7SWP63 dated September 04, 2025.

Does the Form 6-K state the transaction price for the GSK trade?

No. The supplied content does not include any transaction price or price per share.

Who reported the transaction in the GSK Form 6-K?

The provided text does not identify the reporting person or counterparty.

Can the total value of the disclosed GSK transaction be calculated from this filing?

No. Because the price is not disclosed, the monetary value of the 10,050 shares cannot be calculated from the provided content.

What security was involved in the disclosed transaction?

The filing references the security with ISIN GB00BN7SWP63.